Why U.S. Investment Plans Start to Feel Risky When Nobody Has Checked the Immigration Piece

The strategic plan to invest in a U.S. enterprise has somehow begun to feel risky, yet no one involved can put their finger on precisely why. The deal has been formulated, the capital, for the most part, committed, and the principal investor even has a specific individual in mind for the ground role in the U.S. As the planning continues, your growing uneasiness, you suspect, comes from the fact that the plan has yet to be tested against the realities of the visa requirements: the one area of contract negotiation and business acquisition in which the investor lacks prior experience.

At this point, with such significant commitments of resources and time already made, the investor coalition is beginning to feel reputational pressure. Have real risks been overlooked in the planning? What should be your next step?

At a glance: A UK or Irish U.S. investment plan becomes exposed to immigration risk when the deal structure moves ahead before the visa route has been tested. Ownership, treaty nationality, the person’s U.S. role, timing, source-of-funds evidence, and long-term residence goals can all affect whether E-2, L-1A, EB-5, or another route is viable. These are deal-risk issues, not administrative details, and they are safest to review before closing.

Why it feels risky even when you cannot yet name the problem

What you’re seeing

• Everyone at the board meeting nods when the U.S. expansion topic is brought up, but when someone asks, “Who is going to be on the ground running things there?” no one seems to have the answer.
• The deal timeline has hardened, yet the immigration timeline has not been tested against it.
• Conversations with U.S. counsel, UK solicitors, and tax advisers seem to produce slightly different answers. No one seems to own the visa question end-to-end.
• You have read USCIS pages and a couple of law firm explainers. The feeling afterwards is less clarity, not more.
• There is a worry, mostly after hours, that something significant is being left unresolved.

These are not administrative frustrations. They are early warning signs that your investment plan and immigration plan are not being tested against each other. The risk is that structural decisions may already have been made (entity type, ownership percentages, co-investor arrangements) that narrow or eliminate the visa routes you were assuming would be available.

The six assumptions most UK and Irish investors are making without realising

1. “We are a UK company, so the E-2 will obviously apply.”

Why it feels right: The UK is a treaty country. The UK and the U.S. have maintained a treaty of commerce and navigation since 1815, specifically the Convention to Regulate the Commerce between the Territories of the United States and of His Britannic Majesty, which entered into force on 3 July 1815.

What has not been tested: The E-2 nationality test is applied both to the individual applicant and to the U.S. enterprise itself. The U.S. enterprise must be owned at least 50% by nationals of the treaty country. In a PE-backed acquisition, a holding-company structure, or a joint venture with non-UK co-investors, that 50% threshold is frequently not met on a closer look. There is also a UK-specific residency requirement: UK nationals must be resident or domiciled in the British Isles, Channel Islands, or Gibraltar at the time of application. Dual nationals who obtained UK citizenship through an investment programme may face an additional three-year domicile.

2. “Our Irish entity has the same E-2 treatment as the UK.”

Why it feels right: Both the UK and Ireland are E-2 treaty countries, and both nationalities can apply for E-2 visas.

What has not been tested: The UK and Ireland apply under different bilateral instruments. Ireland’s E-2 treaty basis is structurally different. Irish nationals apply under the 1950 Treaty of Friendship, Commerce and Navigation between Ireland and the United States, as supplemented by a Protocol signed in Washington on 24 June 1992 and brought into force on 18 November 1992, which added the treaty-investor provisions. UK nationals apply under the 1815 Convention. The two routes therefore have different documentary expectations and different consular processes: London for UK applicants, Dublin for Irish applicants.

Dual Irish-UK nationals must also make a conscious choice about which nationality to apply under. Treating the two interchangeably is one of the most common, and most expensive, early mistakes.

3. “We will just use the L-1A because it is an intra-company move.”

Why it feels right: The L-1A is a well-known route for moving managers and executives into the U.S., and it does not depend on treaty-country nationality.

What has not been tested: The L-1A requires a qualifying corporate relationship, such as parent, subsidiary, branch, or affiliate, between the foreign employer and the U.S. entity. The transferring employee must also have worked in a managerial or executive capacity for the foreign employer for at least one continuous year within the three years immediately preceding the petition.

In an acquisition scenario, the qualifying relationship can be legally fragile. If the U.S. target is absorbed rather than kept as a subsidiary, or if the corporate structure is reorganised post-closing, the L-1A basis can disappear. The one-year prior-employment requirement also catches newly hired executives off guard.

If the U.S. operation is newly established, additional evidence may be needed to show that the U.S. office can support an executive or managerial role within the required timeframe.

4. “The EB-5 is a Plan B we can fall back on if the E-2 does not work out.”

Why it feels right: EB-5 is well known as an investor green card route. It can look like a natural fallback if the E-2 does not fit.

What has not been tested: EB-5 is not simply a backup version of the E-2. It is a different legal route, with different capital requirements, documentation, timelines, and risk. The current minimum investment is $800,000 for a qualifying Targeted Employment Area or infrastructure project, and $1,050,000 elsewhere. The investment must also create, or in limited cases preserve, at least ten full-time jobs for qualifying U.S. workers.

The source-of-funds analysis is often the part investors underestimate. For investors with wealth from private equity, venture capital, inherited assets, offshore accounts, or complex corporate structures, documenting the lawful path of funds can take longer than expected.

There are also two dates investors should not confuse. The EB-5 Regional Center Program is currently authorised through 30 September 2027, but the grandfathering protection under the EB-5 Reform and Integrity Act of 2022 is tied to 30 September 2026. A filing strategy that treats those dates as the same can create avoidable risk.

5. “The Gold Card is the new fast track. We can just pay to skip the queue.”

Why it feels right: The Gold Card has generated substantial media coverage, including among UK and Irish investor networks, and is described in shorthand as “pay $1 million for expedited green card eligibility.”

What has not been tested: The Gold Card, introduced by executive order in September 2025, is a $1 million non-refundable contribution to the U.S. Department of Commerce, treated as a gift, that is intended to support expedited eligibility for a green card under existing EB-1A, extraordinary ability, or EB-2 NIW, national interest waiver, categories. A $2 million Corporate Gold Card variant allows an employer to sponsor an employee. A $15,000 non-refundable processing fee applies per person.

The financial contribution does not replace the substantive eligibility criteria of EB-1A or EB-2 NIW. An applicant who does not independently meet extraordinary ability or national interest waiver standards is not made eligible by the payment.

The programme also operates by executive order only and has no Congressional statutory basis. Legal challenges are pending. Current implementation should be checked before filing strategy is set, including whether the applicant must consular process or whether any adjustment-of-status path is available.

For most UK and Irish company investors, the E-2, L-1A, and EB-5 remain the primary and more legally established routes.

The Gold Card is relevant for a narrow group of very high-net-worth individuals who also independently qualify under EB-1A or EB-2 NIW. Treating it as a routine fallback is a strategy decision with real legal and policy risk.

6. “The visa will sort itself out once the deal closes.”

Why it feels right: Deals have always had administrative loose ends that get tidied up post-close.

What has not been tested: Immigration is not administrative in this context. It is structural. Decisions made pre-close, such as entity type, ownership percentages, board composition, and the precise form of the corporate relationship between the UK or Irish parent and the U.S. entity, can limit or eliminate specific visa routes.

Post-close restructuring to meet visa requirements is possible, but it is more expensive, slower, and sometimes not feasible at all. The investors who avoid this cost are the ones who put immigration on the deal checklist, not on the integration checklist.

The question: Who owns the immigration piece on your deal?

UK counsel typically scopes out U.S. immigration on the basis that it is U.S. law. U.S. deal counsel typically scopes it out on the basis that it is specialist immigration work, not corporate. The accountant assumes someone else has this. The relocating executive assumes the company is handling it. The CEO assumes the Managing Director is handling it. The Managing Director assumes HR is. HR, if there is one, is often hearing about the deal for the first time.

The result is an ownership gap. The immigration question sits in the middle of the deal with nobody driving it. This is exactly how U.S. investment plans drift into risk, because nobody explicitly took the question.

Ask these questions:

1. Who, by name, is responsible for the U.S. immigration plan on this deal?
2. What assumptions are they working from, and have those assumptions been confirmed in writing?
3. Has any of the deal documentation, such as the share purchase agreement, shareholders’ agreement, or employment contracts, been reviewed by a U.S. immigration lawyer for visa implications?
4. What is the immigration timeline, and is it aligned with the deal timeline or stapled on after?
5. If the Managing Director, founder, or principal cannot get a visa on the assumed timeline, what is the fallback? Does that fallback have its own eligibility questions that have been tested?

The three kinds of investor plans that are most exposed

Three investor situations come up repeatedly in our practice. If your deal looks like one of them, the exposure is probably specific to that pattern, not general.

1. The PE-backed or co-invested acquisition

What is typically exposed: The 50% treaty-nationality threshold for the E-2. When the acquiring entity has co-investors from non-treaty countries, or the fund structure is multinational, the threshold may not be met even though the lead investor is UK or Irish. The L-1A may become the default, but only if the corporate relationship is structured correctly from the outset.

2. The Irish or UK founder-operator building a U.S. presence

What is typically exposed: The develop-and-direct requirement for the E-2 when a founder has taken investment that dilutes their ownership below 50%; the source-of-funds trail when personal wealth has been combined with investor capital; and the family and timing questions when the founder’s move is bundled with a spouse’s career, children’s school placements, and a U.S. property purchase.

3. The existing E-2 holder with a longer-term residency plan

What is typically exposed: The assumption that the E-2 will simply convert to a green card. The E-2 is a non-immigrant visa and does not lead directly to permanent residence. An investor planning to stay long-term needs a pathway, typically EB-5, or in narrow cases EB-1A or EB-2 NIW, and that pathway needs to be planned years in advance, not at the point when renewal is approaching.

Why UK and Irish investors in 2026 face a narrower window

Several 2025-2026 policy shifts have tightened the landscape in ways that are specifically relevant to UK and Irish investors:

1. The EB-5 grandfathering deadline of 30 September 2026 is approaching. Petitions filed on or before that date are protected by the EB-5 Reform and Integrity Act of 2022 even if the Regional Center Program is not reauthorised. The program itself is authorised through 30 September 2027. Filing between those two dates is legally permissible but not grandfathered. Investors who file after the grandfathering deadline carry reauthorisation risk.
2. E-2 consular processing at the U.S. Embassy in London has been taking longer and is reportedly subject to more variable interview scrutiny under rotating officer assignments. Applicants should budget roughly 90 working days from filing, with longer interviews than in previous years.
3. The September 2025 H-1B proclamation does not directly change the investor routes discussed here, but it may affect companies that were considering H-1B as part of a wider U.S. staffing or expansion plan.
4. Source-of-funds expectations have tightened across EB-5 adjudications. Investors with complex PE or VC fund structures, inherited wealth, or offshore accounts should expect to start their documentation significantly earlier than they previously would have.
5. Cross-border deal scrutiny more generally, including CFIUS review in sensitive sectors, outbound investment restrictions, and anti-money-laundering expectations, has intensified. A lawyer who understands the investor’s full regulatory environment is more valuable than one who looks only at the visa.

The practical effect: investors who would have had a comfortable runway two years ago now have a narrower one.

What to do before the unease turns into a cost

The reason a U.S. investment plan starts to feel risky is almost never a single legal issue. It is the accumulation of unexamined assumptions about ownership, nationality, timing, and route. The investors who avoid costs are the ones who test those assumptions early, before the deal closes and before structural decisions are locked in. Getting an honest immigration assessment at the point at which the plan first feels exposed is the most effective way to protect the investment.

If your U.S. investment plan is starting to feel risky in ways you cannot quite name, Flynn Hodkinson will give you an honest, structured assessment of where the exposure actually is. We review the deal structure, the ownership, the intended role, and the timeline, and tell you plainly whether the plan as it stands is viable, and what would need to change if it is not.

This post is for informational purposes only and is not intended as legal advice. If you require further assistance or advice relating to the above, please contact janice@flynnhodkinson.com.